Sleep disturbances reported by partial-onset epilepsy patients receiving polytherapy

被引:0
作者
Bazil, C
Xu, X
Brandenburg, N
机构
[1] Columbia Univ, New York, NY USA
[2] Covance, Gaithersburg, MD USA
[3] Pfizer Inc, Pfizer Global Pharmaceut, Hlth Outcomes Res, New York, NY USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:182 / 182
页数:1
相关论文
共 50 条
[1]   Sleep disturbances reported by partial-onset epilepsy patients receiving polytherapy [J].
McDermott, A ;
Brandenburg, N ;
Xu, X ;
Bazil, C .
EPILEPSIA, 2004, 45 :279-279
[2]   Sleep disturbances reported by partial-onset epilepsy patients receiving polytherapy [J].
Brandenburg, N. ;
Xu, X. ;
Bazi, C. .
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 :120-120
[3]   Sleep disturbances reported by refractory partial-onset epilepsy patients receiving polytherapy [J].
Xu, Xiao ;
Brandenburg, Nancy A. ;
McDermott, Anne M. ;
Bazil, Carl W. .
EPILEPSIA, 2006, 47 (07) :1176-1183
[4]   Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy [J].
Hoy, Sheridan M. .
CNS DRUGS, 2016, 30 (08) :761-772
[5]   Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy [J].
Sheridan M. Hoy .
CNS Drugs, 2016, 30 :761-772
[6]   New developments in the treatment of partial-onset epilepsy [J].
Besag, Frank M. C. ;
Patsalos, Philip N. .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 :455-464
[7]   Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures [J].
Brown, Martin E. ;
El-Mallakh, Rif S. .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 :103-109
[8]   Retigabine (Ezogabine) In Partial-Onset Seizures in Adults with Epilepsy [J].
Deeks, Emma D. .
CNS DRUGS, 2011, 25 (10) :887-900
[9]   SLEEP PATTERNS IN PATIENTS WITH LATE ONSET PARTIAL EPILEPSY RECEIVING CHRONIC CARBAMAZEPINE (CBZ) THERAPY [J].
MANNI, R ;
GALIMBERTI, CA ;
ZUCCA, C ;
PARIETTI, L ;
TARTARA, A .
EPILEPSY RESEARCH, 1990, 7 (01) :72-76
[10]   Emerging drugs for partial-onset epilepsy: a review of brivaracetam [J].
Gao, Lan ;
Li, Shuchuen .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 :719-734